TAE and UKAEA launch joint venture to commercialize fusion beam tech

Neutral beams, not the logo on the press release, are the real story here. TAE Technologies and the UK Atomic Energy Authority have formally established TAE Beam UK, a fully funded joint venture based at UKAEA’s Culham Campus in Oxfordshire, and the move gives the fusion sector something more tangible than another alliance headline: a dedicated effort to turn a critical beamline technology into an industrial product.

The venture was first announced on December 2, 2025, when UKAEA said it would put £5.6 million into the company as part of a reciprocal investment commitment with TAE. By May 14, 2026, TAE said the joint venture had been formally established in the UK and was now fully funded, marking the shift from agreement to execution. That matters because the work is aimed at one of fusion’s stubborn bottlenecks. Neutral beams are used to heat and sustain plasma, and without that kind of enabling hardware, reactor concepts stay stuck on paper or in the lab.

Culham gives the venture a practical base with deep institutional muscle behind it. UKAEA has more than 40 years of fusion research experience and has operated the Joint European Torus neutral beam system for decades. TAE is bringing its own long runway to the table, including more than two decades of patented intellectual property and particle accelerator research. On its current fusion machine, the company says it uses eight neutral beams positioned at precise angles, and it says it was the first to use neutral beams both for field-reversed configuration plasma formation and for sustaining high-quality plasma.

That combination is why this looks less like a rebrand of an old partnership and more like a commercialization step. Tim Bestwick, UKAEA’s chief executive, said the formalization and funding showed clear commitment and progress toward commercialization. Michl Binderbauer, TAE’s chief executive, has framed neutral beams as a key component for commercial fusion power. The venture is meant to translate accelerator know-how into deployable systems, not just for fusion but for cancer treatment, food safety, homeland security, and other medical and industrial uses.

TAE also said it has additional UK facilities through TAE Power Solutions in the West Midlands, widening the British footprint around the venture. For a field that often advances through obscure subsystems rather than headline-grabbing reactor milestones, TAE Beam UK is the kind of marker that fusion watchers can actually track: funding in place, a site in place, and the beam tech that could feed the next phase of the build.